Results per Page:
Dr. Jingyi Jessica Li named Donald and Janet K. Guthrie Endowed Chair in Statistics
Funding will help new program head expand applied use of statistics in cancer research
For Fred Hutch biostatisticians, numbers are no game
Meticulous work at the SWOG Statistics and Data Management Center, housed at Fred Hutch, may alter care for bladder cancer and lymphoma
How a Black woman is coping with an ‘old white man’s disease’
Bladder cancer patient manages the stress of a disease where recurrence is common
Bridging the gap between cancer drug target and cancer drug
Fred Hutch RNA-translation expert Dr. Andrew Hsieh receives Harrington Scholar-Innovator Award to develop experimental compound into anti-cancer drug
A model that reflects the genetic complexity and heterogeneity of human cancers
From the Lee Lab, Human Biology Division
Cancer care: From ‘sledgehammer’ to precision cellular therapy
AACR progress report: new immunotherapies improve outcomes, but access to care and clinical trials for many still lags
Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous
Bladder cells’ strategy blocks cancer-causing genetic programs, could be new therapeutic target
Dr. Andrew Hsieh elected member of American Society for Clinical Investigation
Physician-scientist demonstrated central role protein synthesis plays in cancer
Tip Sheet: Massive unmet needs in COVID-19 treatment, osteoporosis drugs for breast cancer, new bladder cancer target — and AIDS at 40
Summaries of recent Fred Hutch research findings and other news
Researchers ID potential new drug target in bladder cancer
Experimental drug that reduces protein production slows disease progression in lab studies
New tumor models for the development of bladder cancer therapies
From the Human Biology Division Hsieh laboratory and the UW Department of Urology
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Comparing sexual quality of life among survivors of prostate, bladder, colorectal, and lung cancer
From the Ramsey Group, Public Health Sciences Division